Crown Equity Holdings, Inc. (CRWE)
VoIP which is a short phrase for Voice over Internet Protocol is also known as broadband phone. It is called as broadband phone because it needs broadband internet connection either to receive or make a call. This is the technology which allows your conversation into digital signal which is converted over the internet and then to voice after when it reaches the final destination.
The most important advantage of VoIP is reduction in cost. Since it is a voice over internet, it is considered as data service and you will be exempted from the fees of long distance. This is the reason many VoIP service provider offer low rates for long distance and internationals calls.
Crown Equity Holdings Inc. (CRWE) is pleased to announce that it has entered into a joint venture to deploy VoIP (Voice over Internet Protocol) technology delivering voice, video and data services to residential and commercial customers. The joint venture company is Crown Tele Services Inc. which was a wholly-owned subsidiary of Crown Equity Holdings Inc. Crown Equity Holdings Inc. will own fifty percent (50%) interest in the joint venture.
Commenting on the joint venture, Kenneth Bosket, President of Crown Equity Holdings Inc., said: "We are excited to deliver VoIP communications solutions specifically designed to meet the business and residential market needs in this fast-growing global market."
Crown Equity Holdings, Inc., together with its digital network, currently provides electronic media services specializing in online publishing, which brings together targeted audiences and advertisers. Crown Equity Holdings Inc. offers internet media-driven advertising services, which covers and connects a range of marketing specialties, as well as search engine optimization for clients interested in online media awareness.
For more information please visit official website of CRWE: www.crownequityholdings.com
**************************
EnzoBiochem Inc. (ENZ)
Biotechnology is the application of biological organisms, system or process to manufacturing and service industries. Biotechnology is the integrated use of biochemistry, microbiology, and engineering sciences in order to achieve technological (industrial) application of the capabilities of micro-organisms, cultured tissue cells and parts thereof. Biotechnology is a technology using biological phenomena for copying and manufacturing various kinds of useful substances. Biotechnology is the controlled use of biological agents, such as microorganisms or cellular components, for beneficial use.
EnzoBiochem, Inc., is a growth-oriented integrated life sciences and biotechnology company focused on harnessing biological process to develop research tools, diagnostics and therapeutics, and serves as a provider of test services, including exotic tests, to the medical community. Since ENZ was founded in 1976, their strategic focus has been on the development of enabling technologies in the life sciences field.
EnzoBiochem Inc. recently announced that it has added four highly experienced executives at its Enzo Life Sciences subsidiary to focus on rapidly evolving new pharmaceutical and clinical applications.
The officers, all filling newly created positions, are Bruce Taillon, PhD, as head of global technology business development, John D'Errico, PhD, to lead the commercial merchandising operations, Kara Cannon, as head of global marketing and Paul Munger, PhD, to lead Global Manufacturing.
Read the full article and the disclaimer at
ennyotcstock.com/?p=17232
(MTH, CRWE, ENZ, STI) Stock Highlights by PennyOTCStock.com
September 22nd, 2011 at 03:58 pm